Browsing by Author "Rodrigues, Natalia Fintelman"
Now showing items 16-29 of 29
-
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, Suelen da Silva Gomes et al. | Date Issued: 2020 -
Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
Gomes, Larissa R. et al. | Date Issued: 2021 -
Non-permissive SARS-CoV-2 infection in human neurospheres
Pedrosa, Carolina da Silva Gouveia et al. | Date Issued: 2021 -
Non-permissive SARS-CoV-2 infection in human neurospheres
Pedrosa, Carolina da Silva Gouveia et al. | Date Issued: 2021 -
Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance
Souza, Thiago Moreno Lopes e et al. | Date Issued: 2015 -
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARSCoV- 2 variants with high potency
Cunha, Luis Eduardo R. et al. | Date Issued: 2021 -
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Souza, Thiago Moreno L. et al. | Date Issued: 2023O artigo trata do desenvolvimento de um antiviral de uso oral contra a Covid-19. A substância, batizada de MB-905, foi purificada a partir da cinetina e demonstrou-se eficaz para inibir a replicação do Sars-CoV-2 em linhagens ... -
Repurposing the Ebola and Marburg virus inhibitors tilorone, quinacrine, and pyronaridine: in vitro activity against SARS-CoV‑2 and potential mechanisms
Puhl, Ana C. et al. | Date Issued: 2021 -
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, André C. et al. | Date Issued: 2021 -
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
Lechuga, Guilherme Curty et al. | Date Issued: 2021 -
Synthesis of Polycaprolatone nanoparticles with potential application as Antiviral carrier against Neurological effects of COVID-19
Pereira, Kaique Alves Brayner et al. | Date Issued: 2021 -
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Sacramento, Carolina Q. et al. | Date Issued: 2017 -
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
Temerozo, Jairo R. et al. | Date Issued: 2022 -
WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
Aragão, Luiz Guilherme H. S. et al. | Date Issued: 2021